1.
Chen Y, Farrer RA, Giamberardino C, et al. Microevolution of Serial Clinical Isolates of Cryptococcus neoformans var. grubii and C. gattii. MBio. 2017;8(2). doi:10.1128/mBio.00166-17.
1.
Cuomo CA, Rhodes J, Desjardins CA. Advances in Cryptococcus genomics: insights into the evolution of pathogenesis. Mem Inst Oswaldo Cruz. 2018;113(7):e170473. doi:10.1590/0074-02760170473.
1.
Farrer RA, Ford CB, Rhodes J, et al. Transcriptional Heterogeneity of VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways. mSphere. 2018;3(5). doi:10.1128/mSphere.00445-18.
1.
Passer AR, Coelho MA, Billmyre RB, et al. Genetic and Genomic Analyses Reveal Boundaries between Species Closely Related to Pathogens. mBio. 2019;10(3). doi:10.1128/mBio.00764-19.
1.
D’Souza CA, Kronstad JW, Taylor G, et al. Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio. 2011;2(1):e00342-10. doi:10.1128/mBio.00342-10.
1.
Billmyre B, Croll D, Li W, et al. Highly recombinant VGII Cryptococcus gattii population develops clonal outbreak clusters through both sexual macroevolution and asexual microevolution. MBio. 2014;5(4):e01494-14. doi:10.1128/mBio.01494-14.
1.
Farrer RA, Desjardins CA, Sakthikumar S, et al. Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii. MBio. 2015;6(5):e00868-15. doi:10.1128/mBio.00868-15.